Overview of Dr. Goland
Dr. Robin Goland is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 37 years. Dr. Goland accepts several types of health insurance, listed below. She is one of 142 doctors at New York-Presbyterian Hospital and one of 58 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Endocrinology. She has more than 100 publications and over 500 citings.
Office
1150 Saint Nicholas Ave
2ND FL
New York, NY 10032Fax+1 212-851-5493
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1986
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1980 - 1984
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1980
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 1982 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2012, 2014
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
- Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01
- TODAY Genetics Study Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsCORTICOTROPIN-RELEASING HORMONE STIMULATES STEROIDOGENESIS IN CULTURED HUMAN ADRENAL CELLSC. Richard Parker, Ana K. Stankovic, Robin Goland
Molecular and Cellular Endocrinology. 1999-09-10 - 34 citationsSafety and tolerability of the treatment of youth-onset type 2 diabetes: The TODAY experienceNeil H. White, Laura Pyle, Steven M. Willi, Trang Pham, Steven D. Chernausek
Diabetes Care. 2013-06-01 - 252 citationsInterleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.Antoinette Moran, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman
Lancet. 2013-06-01
Journal Articles
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults with Type 1 DiabetesRobin Goland, David Liljenquist, Ruth S Weinstock, JAMA
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesAnuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
Authored Content
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults with Type 1 DiabetesJune 2020
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020
Press Mentions
- New Initiative Explores Obesity-Brain ConnectionApril 5th, 2017
- American Lifespan Declines as Obesity and Opioid Epidemic Takes Its TollDecember 20th, 2016
- Obesity-Linked Diabetes in Children Resists TreatmentApril 29th, 2012
- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOGreat West PPO
HIP of New York - Select PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: